301. Risk of Virologic Failure with Antiretroviral Switches in HIV/HCV Co-infections

BACKGROUND: Direct-acting antivirals (DAA) and antiretroviral (ARV) medications pose treatment challenges in HIV/HCV co-infection. Management of contraindicated combinations varies across practices. ARV switches may increase the risk of HIV virologic and treatment failure, and has been reported to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosquera, Diana M, Wilder, Julius, Ellis, Alicia, Naggie, Susanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810675/
http://dx.doi.org/10.1093/ofid/ofz360.2506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810675/
http://dx.doi.org/10.1093/ofid/ofz360.2506

Ejemplares similares